Early Identification and Treatment of Rare Cardiomyopathy Cohorts
Not Applicable
Not yet recruiting
- Conditions
- Hypertrophic Cardiomyopathy (HCM)Dilated Cardiomyopathy (DCM)Metabolic CardiomyopathyRestrictive Cardiomyopathy
- Interventions
- Drug: diuretics, ACEIs/ARBs, beta blockers, positive inotropic drugs, MRAs, SGLT2i, retinoidsBehavioral: Close follow-upBehavioral: early rehabilitation guidance
- First Posted Date
- 2025-01-27
- Last Posted Date
- 2025-01-27
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06794710
- Locations
- 🇨🇳
Renji Hospital, Shanghai, Shanghai, China
Efficacy Study of DeepDDH System in Screening Infants with Developmental Dysplasia of the Hip (DDH)
Not Applicable
Not yet recruiting
- Conditions
- Hip Dysplasia, Developmental
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 1976
- Registration Number
- NCT06765525
- Locations
- 🇨🇳
Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
The Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour Imaging
Not Applicable
Recruiting
- Conditions
- Bladder Cancer
- First Posted Date
- 2025-01-08
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06763354
- Locations
- 🇨🇳
Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC
Not Applicable
Active, not recruiting
- Conditions
- Esophageal Squamous Cell Carcinoma (ESCC)
- Interventions
- Radiation: Neoadjuvant ChemoradiotherapyDrug: neoadjuvant immunotherapyProcedure: SurgeryDrug: adjuvant immunotherapy
- First Posted Date
- 2025-01-07
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06762158
- Locations
- 🇨🇳
Radiation Oncology Department, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Development of AI Model for Renal Tumor Diagnosis Using CT and Lab Tests
Completed
- Conditions
- Renal Tumors
- First Posted Date
- 2025-01-07
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 1922
- Registration Number
- NCT06761742
- Locations
- 🇨🇳
Shanghai Jiaotong University School of Medicine, Renji Hospital, Shanghai, Shanghai, China
Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage
Phase 4
Recruiting
- Conditions
- Postpartum HemorrhageSystemic Autoimmune Diseases
- Interventions
- Drug: normal saline
- First Posted Date
- 2024-12-31
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 276
- Registration Number
- NCT06754371
- Locations
- 🇨🇳
Renji Hospital, Shanghai Jiaotong University, School of Medcine, Shanghai, Shanghai, China
Risk Factors for Postpartum Hemorrhage
Completed
- Conditions
- Postpartum HemorrhageSystemic Autoimmune Diseases
- First Posted Date
- 2024-12-12
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 1757
- Registration Number
- NCT06730919
- Locations
- 🇨🇳
Renji Hospital, Shanghai Jiaotong University, School of Medcine, Shanghai, Shanghai, China
A Prospective，Single Arm, Multicenter Clinical Study of BTLA Monoclonal Antibody JS004 (B/T Lymphocyte Attenuator Factor Monoclonal Antibody) in Combination With Toripalimab in Patients With Unresectable or Advanced Renal Cell Carcinoma Who Had Failed Previous Immunotherapy
Phase 2
Not yet recruiting
- Conditions
- Unresectable or Advanced Clear Cell Renal Cell Carcinoma That Has Progressed After Previous Immunotherapy
- Interventions
- Drug: JS004（BTLA monoclonal antibody，intravenously）,Toripalimab（ anti-PD-1specific antibody，intravenously)
- First Posted Date
- 2024-12-12
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 31
- Registration Number
- NCT06730932
- Locations
- 🇨🇳
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China, China
Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China
Recruiting
- Conditions
- CancerCancer-related Problem/Condition
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 322
- Registration Number
- NCT06717178
- Locations
- 🇨🇳
Henan Cancer Hospital, Zhengzhou, Henan, China
🇨🇳Renji Hospital, Shanghai, Shanghai, China
Zero Ischemia Robot-Assisted MWA Assisted Suture-less Tumor Enucleation of RCC With T1 Stage
Not Applicable
Recruiting
- Conditions
- Kidney Neoplasms
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT06715878
- Locations
- 🇨🇳
Ethics Committee of Shanghai Renji Hospital, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath